Vall d'Hebron Institute of Oncology

Vall d'Hebron Institute of Oncology (VHIO) is a center of biomedical research with scientists and physicians working together at the nexus of basic science and clinical research. Its main purpose is to promote and develop research excellence relating to oncological diseases. VHIO also pursues to make contributions to the development of new and better therapies for the treatment of cancer.


Subscribe to rss feed

Oncology & Cancer

Novel agent reactivates an immune call by LIF blockade

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T cells to target and eliminate cancer. ...

Oncology & Cancer

Pushing MYC inhibition closer to the clinic

Cutting-edge sequencing technology has revolutionized cancer diagnosis and since identified several so-called cancer driver genomic aberrations. This has led to the development of an extensive and powerful arsenal of anti-cancer ...